Details for 2024755477

Up to date per 03.04.2026

Actions

Title / Product Name

PHARMAZEUTISCHE FORMULIERUNGEN VON BICTEGRAVIR UND LENACAPAVIR

Status

Granted/Registered

Protection Type

European Patent

(AT-) Application Number

2024755477

EP Publication Number

4531816

E-Number

1872443

Language

PCT Number

US24042251

Publication Date

09.04.2025 A

31.12.2025 B1

Registration Date

31.12.2025

AT Publication Date

15.01.2026

Application Date

14.08.2024

Registration Number

Priorities

15.08.2023

202363519675 P

29.09.2023

23201068

IPC

A61K 9/24 20060101AFI20250519BHEP

Maximum Duration of Protection

14.08.2044

Owner

Gilead Sciences, Inc.333 Lakeside Drive Foster City, CA 94404US

Representative

No representatives present

Inventor

ARORA, Priyanka Foster City, California 94404US

CLAMPFFER, Marina A. Foster City, California 94404US

FOGARTY, Julie A. Foster City, California 94404US

Information about Fees